Price$5.63-0.61 (-9.70%)
01:30 PM07:45 PM
News · 26 weeks55+217%
2026-03-012026-08-23
Mix4090d
- SEC Filings18(45%)
- Market8(20%)
- Insider8(20%)
- Other4(10%)
- Offering2(5%)
Latest news
25 items- SECTenon Medical Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Tenon Medical, Inc. (0001560293) (Filer)
- NEWSTenon Medical Regains Compliance with Nasdaq Minimum Bid Price RequirementLOS GATOS, CA / ACCESS Newswire / August 24, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, today announced that it has received notice from The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Rule").On February 25, 2026, the Company received a letter from the Listing Qualifications staff of Nasdaq (the "Staff") notifying it that, for the prior 30 consecutive business days, the closing bid price of the Company's common stock had been bel
- SECSEC Form EFFECT filed by Tenon Medical Inc.EFFECT - Tenon Medical, Inc. (0001560293) (Filer)
- SECAmendment: SEC Form S-3/A filed by Tenon Medical Inc.S-3/A - Tenon Medical, Inc. (0001560293) (Filer)
- SECSEC Form 10-Q filed by Tenon Medical Inc.10-Q - Tenon Medical, Inc. (0001560293) (Filer)
- SECTenon Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Tenon Medical, Inc. (0001560293) (Filer)
- NEWSTenon Medical Reports Second Quarter 2026 Financial Results~ Second Quarter 2026 Revenue of $1.3 Million, a 127% Increase Compared to Prior Year ~~ Second Quarter Gross Profit of $0.8 Million, a 232% Increase Compared to Prior Year; Gross Margin of 64% ~~ Received FDA 510(k) Clearance for Updated Catamaran® SI Joint Fusion System ~~ Physician and Distributor Training Events Increased 98% in 1H 2026 Compared to 2H 2025, Supporting Record Monthly Case Volume in July 2026 ~~ Closed $4.2 Million Public Offering Subsequent to Quarter End ~ LOS GATOS, CA / ACCESS Newswire / August 13, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic d
- SECSEC Form DEL AM filed by Tenon Medical Inc.DEL AM - Tenon Medical, Inc. (0001560293) (Filer)
- SECSEC Form S-3 filed by Tenon Medical Inc.S-3 - Tenon Medical, Inc. (0001560293) (Filer)
- SECTenon Medical Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Tenon Medical, Inc. (0001560293) (Filer)
- NEWSTenon Medical, Inc. Announces 1:35 Reverse Stock SplitLOS GATOS, CA / ACCESS Newswire / August 6, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, today announced a 1-for-35 reverse stock split of the Company's issued and outstanding common stock.The reverse stock split will become effective at 12:01, Eastern Time, on August 10, 2026, prior to the commencement of trading on the Nasdaq Capital Market. As of that time, each 35 shares of issued and outstanding common stock will be converted into one share of common stock. The Company's common stock is expected to commence trading on a split-adjusted basis when the markets o
- INSIDERDirector Weigle Robert K converted options into 10,732 shares, increasing direct ownership by 142% to 18,284 units (SEC Form 4)4 - Tenon Medical, Inc. (0001560293) (Issuer)
- INSIDERDirector Jacques Kristine M converted options into 10,147 shares, increasing direct ownership by 95% to 20,876 units (SEC Form 4)4 - Tenon Medical, Inc. (0001560293) (Issuer)
- INSIDERDirector Howard Ivan converted options into 10,732 shares, increasing direct ownership by 127% to 19,194 units (SEC Form 4)4 - Tenon Medical, Inc. (0001560293) (Issuer)
- INSIDERDirector Hochschuler Stephen converted options into 10,732 shares, increasing direct ownership by 135% to 18,670 units (SEC Form 4)4 - Tenon Medical, Inc. (0001560293) (Issuer)
- INSIDERDirector Ferrari Richard converted options into 64,479 shares, increasing direct ownership by 91% to 135,243 units (SEC Form 4)4 - Tenon Medical, Inc. (0001560293) (Issuer)
- INSIDERChief Financial Officer Williamson Kevin converted options into 58,987 shares and covered exercise/tax liability with 12,978 shares, increasing direct ownership by 106% to 89,602 units (SEC Form 4)4 - Tenon Medical, Inc. (0001560293) (Issuer)
- INSIDERChief Technology Officer Ginn Richard converted options into 126,577 shares and covered exercise/tax liability with 44,809 shares, increasing direct ownership by 96% to 167,357 units (SEC Form 4)4 - Tenon Medical, Inc. (0001560293) (Issuer)
- INSIDERCEO and President Foster Steven M converted options into 140,936 shares and covered exercise/tax liability with 41,788 shares, increasing direct ownership by 61% to 262,962 units (SEC Form 4)4 - Tenon Medical, Inc. (0001560293) (Issuer)
- NEWSTenon Medical, Inc. Sets Date for Second Quarter 2026 EarningsLOS GATOS, CA / ACCESS Newswire / July 30, 2026 / Tenon Medical, Inc. (NASDAQ:TNON)("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, today announced plans to release financial results for the second quarter ended June 30, 2026 after market close on Thursday, August 13, 2026. The Company will also hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.Date:Thursday, August 13, 2026Time:4:30 p.m. Eastern timeDial-in:1-877-407-0792International Dial-in:1-201-689-8263Webcast:TNON Conf
- SECTenon Medical Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Tenon Medical, Inc. (0001560293) (Filer)
- SECTenon Medical Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Tenon Medical, Inc. (0001560293) (Filer)
- NEWSTenon Medical, Inc. Announces Regained Compliance with Nasdaq Stockholders' Equity RequirementLOS GATOS, CA / ACCESS Newswire / July 20, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, today announced that it has received notice from Nasdaq that the Company regained compliance with the continued listing requirement relating to maintaining a minimum of $2.5 million in stockholders' equity.On July 17, 2026, the Company received a notice from Nasdaq that, based on the July 10 8-K (as defined below), the Company had regained compliance with the Stockholders' Equity Rule (as defined below). However, if the Company fails to evidence compliance upon filing its Quart
- SECSEC Form DEFR14A filed by Tenon Medical Inc.DEFR14A - Tenon Medical, Inc. (0001560293) (Filer)
- SECTenon Medical Inc. filed SEC Form 8-K: Other Events8-K - Tenon Medical, Inc. (0001560293) (Filer)
TNON FAQ
6 questionsWhat does Tenon Medical Inc. do?
Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes. It focuses on sells The CATAMARAN SIJ Fusion System that includes instruments and implants designed to prepare and fixate the SI-Joint for fusion in the United States and Puerto Rico. The company was incorporated in 2012 and is based in Los Gatos, California.Where does TNON stock trade?
Tenon Medical Inc. (TNON) is listed on NASDAQ.What sector and industry is TNON in?
Tenon Medical Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did Tenon Medical Inc. go public?
Tenon Medical Inc. (TNON) completed its IPO in 2022.What companies are similar to TNON?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare TNON side-by-side with any of them on Quantisnow.How can I track TNON on Quantisnow?
Quantisnow aggregates Tenon Medical Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow TNON to receive live email and push alerts on every new disclosure.